Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for iRhythm Holdings, Inc. (IRTC : NSDQ)

• Company Description    IRHYTHM HLDGS is a digital health care company which creates trusted solutions that detect, predict and prevent disease. IRHYTHM HLDGS, formerly known as iRhythm Technologies Inc., is based in SAN FRANCISCO. Number of Employees: 2,000

• Price / Volume Information    Yesterday's Closing Price: $144.21 Daily Weekly Monthly 20 Day Moving Average: 608,536 shares Shares Outstanding: 32.22 (millions) Market Capitalization: $4,646.32 (millions) Beta: 1.06 52 Week High: $212.00 52 Week Low: $92.52 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.73% -12.42% 12 Week -18.90% -21.67% Year To Date -18.73% -18.62%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 699 8th Street Suite 600 - San Francisco,CA 94103 USA ph: 415-632-5700 fax: - investors@irhythmtech.com http://www.irhythmtech.com

• General Corporate Information    Officers Quentin S. Blackford - President and Chief Executive Officer Abhijit Y. Talwalkar - Chairman Daniel Wilson - Chief Financial Officer Marc Rosenbaum - Chief Accounting Officer Bruce G. Bodaken - Director Peer Information iRhythm Holdings, Inc. (HLIS) iRhythm Holdings, Inc. (AZTA) iRhythm Holdings, Inc. (APYI) iRhythm Holdings, Inc. (RNVA) iRhythm Holdings, Inc. (HMSY) iRhythm Holdings, Inc. (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 450056106 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/19/26 Share - Related Items Shares Outstanding: 32.22 Most Recent Split Date: (:1) Beta: 1.06 Market Capitalization: $4,646.32 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.46 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.43 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 35.16% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/19/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 38.12 Price/Cash Flow: - Price / Sales: 6.61 EPS Growth vs. Year Ago Period: 95.24% vs. Previous Quarter: 81.25% Sales Growth vs. Year Ago Period: 30.74% vs. Previous Quarter: 3.32% ROE 12/31/25 - - 09/30/25 - -41.86 06/30/25 - -90.03 ROA 12/31/25 - - 09/30/25 - -4.42 06/30/25 - -8.52 Current Ratio 12/31/25 - - 09/30/25 - 4.63 06/30/25 - 5.02 Quick Ratio 12/31/25 - - 09/30/25 - 4.50 06/30/25 - 4.88 Operating Margin 12/31/25 - - 09/30/25 - -6.00 06/30/25 - -12.09 Net Margin 12/31/25 - - 09/30/25 - -7.32 06/30/25 - -14.06 Pre-Tax Margin 12/31/25 - - 09/30/25 - -7.23 06/30/25 - -13.94 Book Value 12/31/25 - - 09/30/25 - 3.78 06/30/25 - 3.23 Inventory Turnover 12/31/25 - - 09/30/25 - 12.56 06/30/25 - 12.85 Debt-to-Equity 12/31/25 - - 09/30/25 - 5.32 06/30/25 - 6.25 Debt-to-Capital 12/31/25 - - 09/30/25 - 84.18 06/30/25 - 86.21

Powered by Zacks Investment Research ©